Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612352 · ClinicalTrials.gov registry record · NA
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00612352 is a NA study that has completed, run by Yale University. The registered enrollment target is 180 participants.
The verdict
NCT00612352, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Interventions
- DRUG Ethanol High Dose, Ethanol Low Dose, and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2001-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612352
The ClinicalTrials.gov registry entry for NCT00612352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ethanol High Dose, Ethanol Low Dose, and Placebo is the first listed.
NCT00612352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612352 about?
NCT00612352 is a clinical study titled "Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism". The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may l...
What is the current status of trial NCT00612352?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2001-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00612352?
The interventions under investigation include: Ethanol High Dose, Ethanol Low Dose, and Placebo (DRUG).
Who is sponsoring clinical trial NCT00612352?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.